Report
David Nierengarten ...
  • Jeffrey La Rosa
  • Matthew Barcus

FY19 Financials; Awaiting FDA Action Following NDA Submission

Underlying
Fennec Pharma

Provider
Wedbush
Wedbush

Since our founding in 1955, Wedbush has been a leader in the financial industry providing our clients with a wide range of services; including institutional sales, correspondent clearing services, equity research, corporate and municipal finance, equity market making, fixed income trading, prime brokerage, and wealth management. Headquartered in Los Angeles, with 100 registered offices, the firm focuses on dedicated service, client financial safety, continuity, and advanced technology.

Analysts
David Nierengarten

Jeffrey La Rosa

Matthew Barcus

Other Reports on these Companies
Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe
David Nierengarten ...
  • Jeffrey La Rosa
  • Matthew Barcus
Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe
Other Reports from Wedbush
David Nierengarten ...
  • Jeffrey La Rosa
  • Matthew Barcus
Ashiq Mubarack ...
  • Robert Driscoll
Other Reports from these Analysts
David Nierengarten ...
  • Jeffrey La Rosa
  • Matthew Barcus
Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe
Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Matthew Barcus
  • Robert Driscoll

ResearchPool Subscriptions

Get the most out of your insights

Get in touch